Article Details

Could low-cost leprosy drug clofazimine be repurposed for COVID-19?

Retrieved on: 2021-03-17 14:15:00

Tags for this article:

Click the tags to see associated articles and topics

Could low-cost leprosy drug clofazimine be repurposed for COVID-19?. View article details on hiswai:

Excerpt

New COVID-19 drugs such as Gilead Sciences' remdesivir have their limitations, stressing the need for additional therapeutic options. To accelerate ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up